New pill takes on aggressive brain tumors in early trial
Disease control
Recruiting now
This early-stage trial tests an oral drug called GLIX1 in 30 adults with recurrent or progressive high-grade glioma, a fast-growing brain cancer. The study aims to find the safest dose and check for any signs of tumor control. Participants take the drug daily until their disease …
Phase: PHASE1 • Sponsor: Tetragon Biosciences Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC